ClinicalTrials.Veeva

Menu
B

BLC Clinical Research | Burlington, Canada

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

DUPIXENT®
NOC-110
BI 1291583

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 3 total trials

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough (ASPIRE)

This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...

Enrolling
Refractory or Unexplained Chronic Cough
Drug: NOC-110
Other: Placebo

This study is open to adults with bronchiectasis. People can participate in this study if they produce sputum and have had flare-ups (also called exa...

Enrolling
Bronchiectasis
Drug: Placebo matching BI 1291583
Drug: BI 1291583

Trial sponsors

Boehringer Ingelheim logo
N
Regeneron Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems